Methods
A total of two hundred patients aged >12 years (mean 25 + 10 years) were selected from July 2006 to July 2010. The mital valve morphology and severity of stenosis were assessed before the procedure using 2-D, M-mode and colour doppler echocardiography. Transoesophagial echocardiography was done in ten cases, where status of thrumbus was not assertined by transthoracic echocardiography. Exclusion criteria included mitral regurgitation > 2 grade, significant lesions in other valves requiring surgery, infective endocarditis or left atrial thrombus. Informed consent was obtained from all selected patients.
Data Collection
Baseline data including demographic, hemodynamic, echocardiographic and functional status were collected from all patients. Data on performance of the procedure were collected including technique used, balloon types and size, maximal dilating diameter, number and duration of inflation. Serious procedural complications, including but not limited to cardiogenic shock, myocardial infarction, cardiac perforation, cardiac tamponade, acute mitral regurgitation, systemic thromboembolism, development of pulmonary edema and the development of a neurological deficit were recorded on a standardized format was completed on all patients undergoing the procedure.
Statistical Analysis
Data were expressed as mean ± standard deviation. Percentages were based on known values. Mortality and complication rates for patients with and without base line risk factors were analyzed by χ 2 test. Continuous variables were compared with the two sample test. A P value <0.05 was considered significant.
Results
200 cases were selected from indoor and out patient department for mitral commissurotomy. All the patients had rheumatic mitral stenosis. None had significant concomitant regurgitation or aortic valve disease. 50 out of 200 patients had symptoms of NYHA grade I, 130 had grade II-III and 20 had grade III-IV symptoms (Table-I). Table-II) . Technical success defined as a resultant mitral valve area >1.5 cm 2 or 50% increase in MVA was achieved in 95% cases.
The patients were categorized according to the pre & post procedure MVA (Table III) . Post procedural MVA were excellent with similar rate of complications. Complication Table IV and V shows the incidance of minor and major complications of the procedure. Minor complications included mitral regurgitation grade >II <III in 2(1%) cases, vasovagal reaction in 3(1.5%), balloon rupture without sequel in 1(.5%) cases, other minor complications included arrhythmias required treatment, prolonged hypotension, seizure and significant hematoma also occured.
Major (serious) complications like cardiac perforation in 2(1%) patient, cardiac tamponade in 2(1%), emergency cardiac surgery in 3(1.5%), acute mitral regurgitation grade >3 in 4(2%) patient, pulmonary oedema occurred in 7(3.5%) pt. cardiagenic shock occurred in 6(3%) patient and two patient (1%) died within 24 hours of the procedure.
Follow-up Every patient was followed up during hospital period and then after one month clinically and echocardiographically. Of the surgical approaches to the treatment of patients with severe symptomatic mitral stenosis, closed commissurotomy is probably we most like than percutaneous balloon commissurotomy. Mortality rates after surgical closed commissurotomy range from 0.5% to 7.6%. [9] [10] [11] [12] 22, 23 Comroerford and colleagues 15 reported results of closed mitral commissuroitomy in 654 patients.
The overall operative mortality rate was 2.97%, and the incidence of mitral regurgitation severe enough to require re-operation within 30 days was 0.6%.
The results reported in the Balloon Valvuloplasty Registry are comparable to those previously reported in patients undergoing surgical closed mitral commissurotomy. It is interesting that previous reports of patients undergoing closed commissurotomy have noted that operative mortality was highest in older patients as well as those with opening snap by physical examination and in those with mitral valve calcification. 10, 24 We have noted similar findings in patients undergoing percutaneous balloon mitral commissurotomy.
Although percutaneous balloon mitral commissurotomy is difficult to compare with open surgical commissurotomy the comparison is never the less of inserts. Operative mortality varies form zero to 12%, [13] [14] [15] 18 with some authors noting a lower mortality in patients receiving cold cardioplegic arrest 15 and others having seen no difference. 25 The incidence of the development of severe mitral regurgitation appears to be rare, 15 but it must be remembered that, when a sub optimal result occurs with open commissurotomy, the mitral valve is replaced with a prosthesis. Cerebrovascular accident and transient ischemic attacks are uncommon. 13 We have described the results of percutaneous ballon mitral commissurotomy in 200 patients undergoing the procedure in two institutions in Bangladesh. Death occurred in 0.1% patients during the study period.
Although percutaneous balloon mitral commissurotomy appears effective at relieving the hemodynamic effects of rheumatic mitral stenosis, it does have important risks. Complications of the procedure do appear to be importantly affected by the experience of the individual center.
Therefore, an improperly selected patients treated in experienced centers, this procedure can be done with low risk and excellent short-term outcome.
Patients best suited for this procedure include those of younger age without evidence of left atrial possible thrombus by standard two-dimensional echocardiography, those with a lower echo score and considered to have surgical risk.
Transthoracic echocardiography is less sensitive detector of left atrial thrombi that can be correctly diagnosed by transoesphagial echocardiography. In our series we have excluded left atrial thrombi by trans oesophageal echocardiography without any event. We performed PTMC of all our patients without any thrombo-embolic complications.
From our series, percutaneous transvenous mitral commissurotomy (PTMC) seems to be safe and effective treatment in a wide range of Bangladeshi patients with mitral stenosis, and this appears to be and alternative to surgery in patients who are good candidate for commissurotomy. The greatest improvement of valve function concomitant with the lowest incidence of complications is to be expected.
Conclusion
Percutaneous transvenous mitral commissurotomy is an established non-surgical procedure for the treatment of symptomatic mitral stenosis but it is not without risk of complications. It can be safely done in patient with severe intractractable heart failure, pregnancy with mitral stenosis and also in severe disabled bed bound patients with poor general conditions.
